CVS Health Corp vs Williams-Sonoma, Inc. — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while Williams-Sonoma, Inc. trades at $239 (market cap $28.32B). The key difference: CVS Health Corp is far larger — about 4× Williams-Sonoma, Inc.'s market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Williams-Sonoma, Inc. for 59 Days on average.
| CVS | WSM | |
|---|---|---|
Market Cap | $112.49B | $28.32B |
Volume | 8,467,392 | 963,190 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $251.81 |
52-Week Low | $70.08 | $168.64 |
Typical Hold Time | 83 Days | 59 Days |
Enterprise Value | $174.83B | $28.82B |
Dividend Yield | 3.02% | 1.26% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Williams-Sonoma (WSM) trades at $239.00, down 1.35% on the day, with strong technical momentum showing bullish moving averages despite overbought RSI readings. The company demonstrates robust fundamentals with 14.73% net income margin and consistent earnings beats, having exceeded expectations in three consecutive quarters. Recent news highlights the company's market share gains and AI integration driving operational efficiency.
The outlook remains positive with a consensus price target of $246.31 representing 3% upside potential. Key opportunities include sustained margin expansion and business-to-business growth, while risks involve housing market sensitivity and competitive pressures in the home furnishings sector.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →